Trials / Completed
CompletedNCT02454088
A Single-Center Investigator-Initiated Evaluator-Bilateral-Comparison Pilot Study of Injectable Calcium Hydroxylapatite With and Without Triamcinolone Acetate for the Treatment of Volume Loss to Dorsum Areas of the Hands
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Goldman, Butterwick, Fitzpatrick and Groff · Academic / Other
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Accepted
Summary
This will be a single-center, investigator-initiated, double-blinded, randomized, bilateral-comparison pilot study of injectable Calcium hydroxylapatite with and without Triamcinolone acetate for the treatment of volume loss to the dorsum areas of the hands.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Calcium Hydroxylapatite and Triamcinolone acetate | Combination Therapy Triamcinolone acetate and Calcium Hydroxylapatite |
| DEVICE | Calcium Hydroxylapatite and Placebo | Calcium Hydroxylapatite and Placebo |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2016-10-01
- Completion
- 2016-11-01
- First posted
- 2015-05-27
- Last updated
- 2017-03-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02454088. Inclusion in this directory is not an endorsement.